Published in Rev Neurol (Paris) on May 01, 2002
Dysfunction of the magnocellular stream in Alzheimer's disease evaluated by pattern electroretinograms and visual evoked potentials. Brain Res Bull (2010) 0.83
Differential processing of natural scenes in posterior cortical atrophy and in Alzheimer's disease, as measured with a saccade choice task. Front Integr Neurosci (2014) 0.79
Alzheimer's disease: screening biomarkers using frequency doubling technology visual field. ISRN Neurol (2013) 0.76
Screening for Patients with Mild Alzheimer Disease Using Frequency Doubling Technology Perimetry. Neuroophthalmology (2013) 0.75
Scene categorization in Alzheimer's disease: a saccadic choice task. Dement Geriatr Cogn Dis Extra (2015) 0.75
Oscillatory Activities in Neurological Disorders of Elderly: Biomarkers to Target for Neuromodulation. Front Aging Neurosci (2017) 0.75
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology (1999) 3.49
Amnestic syndrome of the medial temporal type identifies prodromal AD: a longitudinal study. Neurology (2007) 2.61
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Comparison of 7.0-T T₂*-magnetic resonance imaging of cerebral bleeds in post-mortem brain sections of Alzheimer patients with their neuropathological correlates. Cerebrovasc Dis (2011) 2.05
Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.81
Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease. J Neurol Neurosurg Psychiatry (2008) 1.71
Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites. Mol Psychiatry (2011) 1.59
Prediction of pathology in primary progressive language and speech disorders. Neurology (2009) 1.57
Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry (2008) 1.56
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry (2009) 1.51
Decreased morbidity from acute bacterial spinal epidural abscesses using computed tomography and nonsurgical treatment in selected patients. Ann Neurol (1985) 1.43
Poststroke dementia: incidence and relationship to prestroke cognitive decline. Neurology (2001) 1.40
Qualitative assessment of cerebral atrophy on MRI: inter- and intra-observer reproducibility in dementia and normal aging. Eur Neurol (1997) 1.36
Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex. Am J Hum Genet (1997) 1.27
White matter changes on CT and MRI: an overview of visual rating scales. European Task Force on Age-Related White Matter Changes. Eur Neurol (1998) 1.25
Outer retinal dysfunction in patients treated with vigabatrin. Neurology (1999) 1.24
Nonoverlapping but synergetic tau and APP pathologies in sporadic Alzheimer's disease. Neurology (2002) 1.22
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Pronounced impact of Th1/E47cs mutation compared with -491 AT mutation on neural APOE gene expression and risk of developing Alzheimer's disease. Hum Mol Genet (1998) 1.20
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol (2012) 1.19
The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet (2000) 1.16
A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's disease. Hum Mol Genet (1998) 1.14
Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology (2002) 1.14
Sleep disorders in aging and dementia. J Nutr Health Aging (2010) 1.10
Confusional state in stroke: relation to preexisting dementia, patient characteristics, and outcome. Stroke (1999) 1.07
Resistance to Bacillus sphaericus involves different mechanisms in Culex pipiens (Diptera:Culicidae) larvae. J Med Entomol (1997) 1.06
Unilateral loss of facial flushing and sweating with contralateral anhidrosis: harlequin syndrome or Adie's syndrome? Clin Auton Res (1993) 1.06
Preexisting dementia in stroke patients. Baseline frequency, associated factors, and outcome. Stroke (1997) 1.03
The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. Eur J Neurol (2011) 1.03
Perception of emotion in frontotemporal dementia and Alzheimer disease. Alzheimer Dis Assoc Disord (1999) 1.01
Medial temporal lobe atrophy in stroke patients: relation to pre-existing dementia. J Neurol Neurosurg Psychiatry (1998) 0.99
[Epidemiology and prevalence of hereditary retinal dystrophies in the Northern France]. J Fr Ophtalmol (1991) 0.99
SPECT data in a case of secondary Capgras delusion. Psychopathology (1994) 0.97
Methylenetetrahydrofolate reductase deficiency revealed by a neuropathy in a psychotic adult. J Neurol Neurosurg Psychiatry (1994) 0.97
Depressive symptoms after stroke and relationship with dementia: A three-year follow-up study. Neurology (2004) 0.96
CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model. Cell Death Dis (2012) 0.94
Alzheimer's disease and frontotemporal dementia are differentiated by discriminant analysis applied to (99m)Tc HmPAO SPECT data. J Neurol Neurosurg Psychiatry (2000) 0.94
Frontotemporal behavioral scale. Alzheimer Dis Assoc Disord (1998) 0.93
White matter changes and poststroke dementia. Dement Geriatr Cogn Disord (1998) 0.93
Identification of novel VMD2 gene mutations in patients with best vitelliform macular dystrophy. Hum Mutat (2001) 0.93
Biochemical staging of synucleinopathy and amyloid deposition in dementia with Lewy bodies. J Neuropathol Exp Neurol (2006) 0.92
Epidemiology of vascular dementia. Haemostasis (1999) 0.92
Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke (2003) 0.92
[Visual evoked potentials and face recognition. Influence of celebrity and emotional expression]. Rev Neurol (Paris) (1993) 0.91
Cognitive decline and survival in Alzheimer's disease according to education level. Dement Geriatr Cogn Disord (2007) 0.90
[Neuropsychological evaluation before and after thalamic stimulation in 9 patients with Parkinson disease]. Rev Neurol (Paris) (1992) 0.90
Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke. J Neurol Neurosurg Psychiatry (2006) 0.90
The nature of semantic memory deficits in Alzheimer's disease: new insights from hyperpriming effects. Brain (2001) 0.89
Association of 3'-UTR polymorphisms of the oxidised LDL receptor 1 (OLR1) gene with Alzheimer's disease. J Med Genet (2003) 0.89
Association between coding variability in the LRP gene and the risk of late-onset Alzheimer's disease. Hum Genet (1999) 0.89
Perception of emotion on faces in frontotemporal dementia and Alzheimer's disease: a longitudinal study. Dement Geriatr Cogn Disord (2004) 0.89
The cognitive syndrome of vascular dementia: implications for clinical trials. Alzheimer Dis Assoc Disord (2000) 0.88
Vascular dementia: the role of cerebral infarcts. Alzheimer Dis Assoc Disord (2000) 0.88
Poststroke dementia. Cerebrovasc Dis (2006) 0.88
Explicit memory in frontotemporal dementia: the role of medial temporal atrophy. Dement Geriatr Cogn Disord (1998) 0.87
[Chiasmatic tuberculoma. 2 cases]. Sem Hop (1984) 0.87
Association between the low density lipoprotein receptor-related protein (LRP) and Alzheimer's disease. Neurosci Lett (1997) 0.86
Iron deposits in post-mortem brains of patients with neurodegenerative and cerebrovascular diseases: a semi-quantitative 7.0 T magnetic resonance imaging study. Eur J Neurol (2014) 0.85
[11 cases of neuropathy induced by almitrine, of which one had optic neuropathy]. Rev Neurol (Paris) (1986) 0.85
Progression of Alzheimer disease in Europe: data from the European ICTUS study. Curr Alzheimer Res (2012) 0.85
[Vitreoretinochoroidal heredo-dystrophy, microcornea, glaucoma and cataract]. J Fr Ophtalmol (1993) 0.85
Detection of microbleeds in post-mortem brains of patients with frontotemporal lobar degeneration: a 7.0-Tesla magnetic resonance imaging study with neuropathological correlates. Eur J Neurol (2012) 0.85
Acute polyradiculoneuropathy after amitriptyline overdose. Br Med J (Clin Res Ed) (1987) 0.84
[The profile of memory disturbance in early Lewy body dementia differs from that in Alzheimer's disease]. Rev Neurol (Paris) (2003) 0.83
A FE65 polymorphism associated with risk of developing sporadic late-onset alzheimer's disease but not with Abeta loading in brains. Neurosci Lett (2000) 0.83
Autonomic and respiratory dysfunction in Charcot-Marie-Tooth disease due to Thr124Met mutation in the myelin protein zero gene. Clin Neurophysiol (2003) 0.83
Evidence for induction of the ornithine transcarbamylase expression in Alzheimer's disease. Mol Psychiatry (2007) 0.83
[Developmental aspects of central serous choroiditis. Functional aspects]. Bull Soc Ophtalmol Fr (1972) 0.83
Generation effect in short-term verbal and visuospatial memory: comparisons between dementia of Alzheimer type and dementia of frontal lobe type. Cortex (1996) 0.83
Superficial siderosis of the central nervous system: a post-mortem 7.0-tesla magnetic resonance imaging study with neuropathological correlates. Cerebrovasc Dis (2013) 0.82
[Ocular and head movements in infarctions of the thalamic region]. Rev Neurol (Paris) (1985) 0.82
Creutzfeldt-Jakob disease: neurophysiologic visual impairments. Neurology (1998) 0.81
[Dementia following bipolar disorder]. Encephale (2008) 0.81
Influence of pre-existing dementia on the risk of post-stroke epileptic seizures. J Neurol Neurosurg Psychiatry (2005) 0.81
Genetic analysis of new French X-linked juvenile retinoschisis kindreds using microsatellite markers closely linked to the RS locus: further narrowing of the RS candidate region. Hum Genet (1995) 0.81
Cerebrovascular lesions in patients with frontotemporal lobar degeneration: a neuropathological study. Neurodegener Dis (2012) 0.81
[VZV-related myelitis: a pathophysiological hypothesis]. Rev Neurol (Paris) (2007) 0.81
Pupillary disturbances in multiple sclerosis: correlation with MRI findings. J Neurol Sci (2001) 0.81
Severe hypoglycorrhachia after subarachnoid hemorrhage. Two cases with spontaneous recovery in adults. Acta Neurol Belg (1987) 0.80
[Polyradiculitis, cerebellar manifestations, Parkinsonian tremor, papillary edema and hemorrhages in eye grounds during treatment with perhexilline maleate: regressive pathology]. Lille Med (1977) 0.80
Disturbance of sensory filtering in dementia with Lewy bodies: comparison with Parkinson's disease dementia and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 0.80
Technetium HMPAO SPECT study in dementia with Lewy bodies, Alzheimer's disease and idiopathic Parkinson's disease. J Nucl Med (1999) 0.80
Calculation and number processing in mild Alzheimer's disease. J Clin Exp Neuropsychol (1995) 0.80
[Benign choroid plexus papilloma. 2 local recurrences and intraventricular seeding]. Neurochirurgie (1986) 0.80
Upbeat and downbeat nystagmus occurring successively in a patient with posterior medullary haemorrhage. J Neurol Neurosurg Psychiatry (1991) 0.80
[Retinochoroidal involvement of type II membranoproliferative glomerulonephritis. An angiographic study with indocyanine green]. J Fr Ophtalmol (1997) 0.79
Oculomotor, postural, and perceptual asymmetries associated with a common cause. Craniofacial asymmetries and asymmetries in vestibular organ anatomy. Ann N Y Acad Sci (1999) 0.79
Melanotic meningioma. Report of a case and review of the literature. Neurochirurgia (Stuttg) (1985) 0.79
[Quantitive evaluation of metamorphopsia in macular disease]. J Fr Ophtalmol (2000) 0.78
Use of denaturing HPLC and automated sequencing to screen the VMD2 gene for mutations associated with Best's vitelliform macular dystrophy. Ophthalmic Genet (2002) 0.78
Determination of medial temporal lobe atrophy in early Alzheimer's disease with computed tomography. Lancet (1994) 0.78
[Functional aspect of retinal pan-photocoagulation]. Bull Soc Ophtalmol Fr (1979) 0.78
[A possible complication of sickle-cell disease: pulmonary aspergillosis]. Rev Med Interne (2005) 0.78
Silent infarcts in stroke patients: patient characteristics and effect on 2-year outcome. J Neurol (2001) 0.78
[Devic's optic neuromyelitis. 4 cases]. Rev Neurol (Paris) (1987) 0.78
Long-term outcome of acute and subacute myelopathies. J Neurol (2009) 0.78